A chronic alcoholic patient presents with increasing abdominal girth. A liver biopsy reveals reddish inclusions within the hepatocytes. What are these inclusions composed of?
A liver biopsy shows 'nutmeg' pattern. Which additional finding would best support chronic passive congestion?
A liver biopsy shows 'ground glass' hepatocytes. Which special stain would best demonstrate viral particles?
Intrahepatic cholestasis is seen in -
Cholesterol gallstones are made up of:-
Which microscopic feature is characteristic of primary biliary cholangitis?
A 50-year-old woman presents with fatigue and jaundice. A liver biopsy shows Mallory-Denk bodies and steatosis. Which condition is most likely?
A 50-year-old man with a history of cirrhosis is found to have multiple liver nodules and elevated alpha-fetoprotein. Which cell type is the origin of this malignancy?
A 45-year-old man presents with jaundice and an enlarged liver. A biopsy shows regenerative nodules surrounded by fibrous bands. Which factor is most responsible for the fibrosis observed in this patient's condition?
A 50-year-old man has a liver biopsy that reveals nodular regeneration of hepatocytes and fibrosis surrounding the nodules. What is the most likely diagnosis?
Explanation: ***Intermediate filaments*** - In chronic alcoholic patients, reddish inclusions within hepatocytes are characteristic of **Mallory bodies** (also known as alcoholic hyaline) [1]. - Mallory bodies are aggregates of **intermediate filaments**, specifically **cytokeratin filaments**, that have been damaged. *Hemosiderin* - **Hemosiderin** is an iron-storage complex and appears as **golden-brown granules** within cells [1]. - While iron overload can occur in alcoholic liver disease, hemosiderin is not the primary component of the reddish inclusions described as Mallory bodies. *Triglycerides* - **Triglycerides** accumulate in hepatocytes in **fatty liver disease** (steatosis), which is common in alcoholics [1]. - These appear as clear lipid vacuoles rather than reddish inclusions. *Glycogen* - **Glycogen** is a branched polysaccharide of glucose, found in the cytoplasm, and appears as clear vacuoles or small, periodic acid-Schiff (PAS)-positive granules. - Hepatic glycogen accumulation is not described as reddish inclusions in the context of alcoholic liver disease. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-390.
Explanation: ***Sinusoidal dilatation*** - **Sinusoidal dilatation** is the **characteristic microscopic feature** of **chronic passive congestion** of the liver, directly responsible for the "nutmeg" appearance [1]. - This dilatation occurs due to increased venous pressure from right-sided heart failure, causing blood to back up into the **hepatic sinusoids**, particularly in **Zone 3 (centrilobular)** around the central veins [3]. - On gross examination, the alternating pattern of congested red-brown centrilobular areas and pale periportal areas creates the classic **nutmeg liver** appearance [1], [2]. *Bridging fibrosis* - **Bridging fibrosis** is a feature of **advanced/late-stage chronic passive congestion**, sometimes called **cardiac cirrhosis** or **cardiac sclerosis** [3]. - While long-standing congestion can eventually lead to centrilobular necrosis and fibrosis, **sinusoidal dilatation** is the **primary and early finding** that best supports the diagnosis. - Bridging fibrosis takes months to years to develop and represents chronic injury, not the acute/characteristic finding [3]. *Mallory bodies* - **Mallory bodies** (Mallory-Denk bodies) are diagnostic hallmarks of **alcoholic hepatitis** or **non-alcoholic steatohepatitis (NASH)**. - They represent aggregates of **intermediate filaments** (cytokeratin) within hepatocytes, unrelated to vascular congestion. *Ground glass hepatocytes* - **Ground-glass hepatocytes** are indicative of **chronic hepatitis B virus infection**, representing accumulated **hepatitis B surface antigen (HBsAg)** in the endoplasmic reticulum. - This finding is completely unrelated to **vascular congestion** or the nutmeg liver pattern. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 126. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 401-402. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 870-872.
Explanation: ***Orcein stain*** - **Orcein stain** specifically highlights **hepatitis B surface antigen (HBsAg)**, which accumulates in the cytoplasm of hepatocytes, producing the characteristic **ground glass appearance** [1]. - This stain helps confirm active **HBV infection** in cases where liver biopsy shows suggestive morphological changes [1]. *PAS stain* - **Periodic Acid-Schiff (PAS) stain** detects **carbohydrates** like glycogen and mucin, and can highlight alpha-1 antitrypsin globules in deficient patients. - While it can stain some viral inclusions, it is not specific for the **ground glass hepatocytes of HBV**. *Ziehl-Neelsen stain* - The **Ziehl-Neelsen stain** is an **acid-fast stain** primarily used to identify **acid-fast bacilli** such as *Mycobacterium tuberculosis*. - It is not used for the detection of **viral particles** or specific liver abnormalities. *Grocott's methenamine silver* - **Grocott's methenamine silver (GMS) stain** is primarily used to detect **fungal organisms** and *Pneumocystis jirovecii* in tissue samples. - It does not stain **viral components** or the characteristic features of **hepatitis B infection**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 843-845.
Explanation: ***Haemochromatosis*** - **Haemochromatosis** is a hereditary disorder characterized by excessive iron absorption and deposition in multiple organs, including the liver [1]. - Iron accumulation in **hepatocytes** causes direct cellular injury and can lead to **intrahepatic cholestasis** as one of its hepatic manifestations [1]. - The progressive iron overload leads to **hepatic fibrosis** and eventually **cirrhosis**, with cholestatic features often present due to hepatocellular dysfunction [1]. - Clinical presentation includes hepatomegaly, elevated liver enzymes, and signs of chronic liver disease including cholestasis. *Galactosemia* - **Galactosemia** is an inherited metabolic disorder affecting galactose metabolism, leading to accumulation of galactose-1-phosphate. - While it causes significant **hepatocellular damage** and can progress to cirrhosis, the primary hepatic manifestation is **hepatocellular injury** rather than cholestasis. - The liver pathology typically shows fatty infiltration, hepatomegaly, and cirrhosis, but **intrahepatic cholestasis is not a characteristic feature** of galactosemia. *Hypercalcemia* - **Hypercalcemia** does not cause **intrahepatic cholestasis** as a primary manifestation. - Its hepatic effects are minimal and typically related to systemic complications or calcification, not direct cholestatic liver disease. *All of the options* - This option is incorrect because only **haemochromatosis** among these conditions is characteristically associated with intrahepatic cholestasis. - Neither galactosemia nor hypercalcemia typically present with cholestasis as a primary hepatic feature. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 854-855.
Explanation: ***Crystalline cholesterol monohydrate*** - **Cholesterol gallstones** primarily consist of **crystalline cholesterol monohydrate**, which forms when the bile becomes supersaturated with cholesterol [1]. - The **crystallization** of cholesterol leads to the formation of visible stones within the gallbladder. *Amorphous cholesterol dihydrate* - This form of cholesterol is not typically found as the primary component of **gallstones**. - **Amorphous** structures lack a defined crystalline lattice and are less stable for forming solid stones. *Amorphous cholesterol monohydrate* - While **cholesterol monohydrate** is the core component, it is in a **crystalline** rather than amorphous state in gallstones [1]. - **Amorphous** forms are generally transient intermediates and do not constitute the bulk of the stones. *Crystalline cholesterol dihydrate* - **Dihydrate** forms of cholesterol are not the main constituent of gallstones; the **monohydrate** form is the predominant type [1]. - The specific hydration state of **cholesterol monohydrate** makes it the primary compound found in the solid, crystalline structure of gallstones [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 882.
Explanation: ***Lymphocytic infiltrates and destruction of bile ducts*** - **Primary biliary cholangitis** is characterized by a **lymphocytic infiltrate** that leads to the destruction of small and medium-sized bile ducts in the portal areas [1]. - This autoimmune response results in **progressive cholestasis** and eventual liver damage [1]. *Noncaseating granulomas* - Noncaseating granulomas are more typical of **sarcoidosis** and **primary sclerosing cholangitis** rather than primary biliary cholangitis. - The presence of **granulomas** does not align with the typical pathology observed in primary biliary cholangitis. *Periductal fibrosis and onion-skinning* - This feature is associated with **primary sclerosing cholangitis**, not primary biliary cholangitis. - In primary biliary cholangitis, lymphocytic infiltrates are more significant than the fibrosis described here. *Fibrosis around bile ducts* - While some fibrosis may be present, it is not a defining feature of primary biliary cholangitis. - The hallmark is the **lymphocytic infiltrates** leading to ductal destruction rather than mere fibrosis around the ducts [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 864-865.
Explanation: ***Alcoholic liver disease*** - The presence of **Mallory-Denk bodies** and **steatosis** on liver biopsy is highly indicative of alcoholic liver disease [1,2]. - Fatigue and jaundice are common symptoms associated with **alcohol-related liver injury**. *Hepatitis C* - While it can cause **fatigue** and **jaundice**, it typically does not show **Mallory-Denk bodies** in liver biopsies. - Hepatitis C is more often associated with **lymphocytic infiltrates** and chronic inflammation rather than steatosis indicative of alcohol abuse. *Non-alcoholic steatohepatitis* - Although it presents with **steatosis**, it commonly lacks the **Mallory-Denk bodies** characteristic of alcoholic liver disease. - Non-alcoholic steatohepatitis is often linked to metabolic syndrome rather than **alcohol consumption**. *Wilson disease* - This genetic condition usually presents with **copper accumulation**, leading to liver dysfunction, but not **Mallory-Denk bodies** [1]. - Symptoms typically include **neurological** disturbances and **keratoconus** rather than solely fatigue and jaundice. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-390. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 848-850.
Explanation: ***Hepatocytes*** - The combination of **cirrhosis**, **multiple liver nodules**, and **elevated alpha-fetoprotein** is highly suggestive of **Hepatocellular Carcinoma (HCC)** [1], [2]. - HCC originates from **malignant transformation of hepatocytes**, the main functional cells of the liver [3]. *Bile duct epithelium* - Malignancies arising from bile duct epithelium are known as **cholangiocarcinomas** [3]. - While cholangiocarcinomas can occur in cirrhotic livers, they typically do not present with significantly elevated **alpha-fetoprotein**. *Kupffer cells* - Kupffer cells are **macrophages** found in the liver. - Malignancies originating from Kupffer cells are extremely rare and are generally classified as **histiocytic sarcomas**, which have a different clinical presentation. *Endothelial cells* - Endothelial cells line the blood vessels, and malignancies derived from these cells in the liver are primarily **hepatic angiosarcomas**. - Hepatic angiosarcomas are rare, clinically aggressive, and are not typically associated with elevated **alpha-fetoprotein** or the same risk factors as HCC. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 878-879. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 398-399.
Explanation: ***Stellate cells secreting TGF-beta*** - **Stellate cells**, upon activation, secrete **transforming growth factor-beta (TGF-beta)**, which plays a crucial role in promoting fibrosis in the liver [1]. - This factor leads to **extracellular matrix deposition** and results in **fibrous bands** surrounding regenerative nodules, characterizing liver fibrosis [1][2]. *Kupffer cells producing cytokines* - While **Kupffer cells** do produce cytokines that mediate inflammation, they are not the primary drivers of **fibrosis** in this scenario. - Their role is more related to immune responses than direct fibrotic changes in connective tissue. *Hepatocytes releasing albumin* - **Hepatocytes** are primarily responsible for synthesizing proteins like **albumin**, but their activity does not directly lead to **fibrosis**. - Their dysfunction can lead to jaundice but does not cause the fibrosis indicated by the biopsy findings. *Macrophages activating NF-kappaB* - Although **macrophages** can activate the **NF-kappaB pathway**, which is involved in inflammation, it does not specifically initiate the **fibrogenic process** associated with liver fibrosis. - The activation of NF-kappaB is more related to inflammatory responses rather than driving the fibrosis observed in this patient's condition. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 830-832. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 381-382.
Explanation: ***Liver cirrhosis*** - The presence of **nodular regeneration of hepatocytes** and **fibrosis** surrounding the nodules is characteristic of cirrhosis [1], indicating chronic liver damage. - Cirrhosis leads to significant architectural changes in the liver [1][2], affecting its function and increasing the risk of complications like liver failure and hepatocellular carcinoma. *Hepatitis* - Hepatitis primarily presents with **inflammation** of the liver and may show necrosis but typically does not present with **nodular regeneration** or significant **fibrosis** on biopsy until it progresses significantly. - Acute or chronic hepatitis can lead to cirrhosis over time but does not have the same nodular appearance at the biopsy stage. *Hepatic steatosis* - Hepatic steatosis, or fatty liver, generally shows **macrovesicular** or **microvesicular fat deposition** and does not typically lead to nodularity or fibrous architecture seen in cirrhosis [1][2]. - It may cause liver enlargement but lacks the **regenerative nodules** present in cirrhotic tissue. *Hepatic adenoma* - **Hepatic adenomas** are benign tumors and would present as well-circumscribed lesions rather than nodular regeneration with fibrosis. - They do not typically cause significant liver architecture changes or fibrosis as seen in cirrhosis. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 395-396. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 850.
Jaundice and Cholestasis
Practice Questions
Viral Hepatitis
Practice Questions
Alcoholic and Non-alcoholic Fatty Liver Disease
Practice Questions
Drug and Toxin Induced Liver Injury
Practice Questions
Cirrhosis and Its Complications
Practice Questions
Metabolic Liver Diseases
Practice Questions
Liver Tumors
Practice Questions
Gallbladder and Biliary Tract Diseases
Practice Questions
Congenital Liver Diseases
Practice Questions
Liver Transplantation Pathology
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free